NCT03867201 - Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients | Biotech Hunter

Enrollment

557

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

August 11, 2021

Study Completion Date

April 30, 2024

Conditions

Migraine

Interventions

BIOLOGICAL

Erenumab

Administered by pre-filled syringe

OTHER

Placebo

Administered by pre-filled syringe

Trial Locations (63)

114

Novartis Investigative Site, Taipei

701

Novartis Investigative Site, Tainan City

1000

Novartis Investigative Site, Manila

1605

Novartis Investigative Site, Pasig

10330

Novartis Investigative Site, Bangkok

10400

Novartis Investigative Site, Bangkok

10449

Novartis Investigative Site, Taipei

11217

Novartis Investigative Site, Taipei

11765

Novartis Investigative Site, Gyeonggi-do

13700

Novartis Investigative Site, Seberang Jaya

18450

Novartis Investigative Site, Hwaseong-si

20400

Novartis Investigative Site, Kuala Terengganu

33305

Novartis Investigative Site, Taoyuan District

40002

Novartis Investigative Site, Khon Kaen

40447

Novartis Investigative Site, Taichung

47000

Novartis Investigative Site, Sungai Buloh

50200

Novartis Investigative Site, Chiang Mai

59100

Novartis Investigative Site, Kuala Lumpur

60002

Novartis Investigative Site, Chiayi City

71004

Novartis Investigative Site, Tainan City

100000

Novartis Investigative Site, Beijing

Novartis Investigative Site, Hanoi

100016

Novartis Investigative Site, Shenyang

100039

Novartis Investigative Site, Beijing

Novartis Investigative Site, Yinchuan

100050

Novartis Investigative Site, Beijing

130021

Novartis Investigative Site, Changchun

130041

Novartis Investigative Site, Changchun

169608

Novartis Investigative Site, Singapore

200040

Novartis Investigative Site, Shanghai

200080

Novartis Investigative Site, Shanghai

210008

Novartis Investigative Site, Nanjing

210029

Novartis Investigative Site, Nanjing

214002

Novartis Investigative Site, Wuxi

215004

Novartis Investigative Site, Suzhou

226014

Novartis Investigative Site, Lucknow

248001

Novartis Investigative Site, Dehradun

250013

Novartis Investigative Site, Jinan

266000

Novartis Investigative Site, Qingdao

310006

Novartis Investigative Site, Hangzhou

310016

Novartis Investigative Site, Hangzhou

361001

Novartis Investigative Site, Xiamen

400016

Novartis Investigative Site, Chongqing

410003

Novartis Investigative Site, Changsha

410008

Novartis Investigative Site, Changsha

411743

Novartis Investigative Site, Taichung County

422005

Novartis Investigative Site, Nashik

430060

Novartis Investigative Site, Wuhan

434020

Novartis Investigative Site, Jingzhou

450052

Novartis Investigative Site, Zhengzhou

500051

Novartis Investigative Site, Shijiazhuang

510000

Novartis Investigative Site, Guangzhou

610041

Novartis Investigative Site, Chengdu

650000

Novartis Investigative Site, Kunming

700000

Novartis Investigative Site, Ho Chi Minh City

710061

Novartis Investigative Site, Xian